Therapeutic Solutions International Inc (TSOI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Therapeutic Solutions International Inc (TSOI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011395
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that provides supplement products. The company offers ProJuvenol, T-Rx and Vital. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for everyday living and promotes cellular rejuvenation. The company’s T-Rx is developed to increase the testosterone levels. Vital is an ati ageing vitalization dietary supplement which increases the bone density, optimize hormone levels for body shaping, reduce fat, improve muscle tone, increase libido and sexual function, and decrease symptoms of stress and anxiety. It markets its products through its sales offices in the US and abroad. Therapeutic Solutions is headquartered in Oceanside, California?, the US.

Therapeutic Solutions International Inc (TSOI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Therapeutic Solutions International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Therapeutic Solutions International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Therapeutic Solutions International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Therapeutic Solutions International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Therapeutic Solutions International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Therapeutic Solutions International Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Therapeutic Solutions Acquires Preterm Labor and Miscarriage Intellectual Property from OmniBiome Therapeutics 10
Partnerships 11
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International for the Assessment of Pregnancy Complications 11
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International 12
Therapeutic Solutions International Enters into Licensing Agreement with Boyd Research and TMD Courses 13
Therapeutic Solutions Enters Into Distribution Agreement With S4S 14
Therapeutic Solutions Enters into Licensing Agreement with Boyd Research 15
Therapeutic Solutions International Inc – Key Competitors 16
Therapeutic Solutions International Inc – Key Employees 17
Therapeutic Solutions International Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Oct 17, 2017: Therapeutic Solutions International strengthens the TSOI Scientific Advisory Board with the Appointment of Pablo A. Guzman, MD 19
Product News 20
Apr 24, 2017: Therapeutic Solutions International’s Subsidiary OmniBiome Announces First Oral Microbiome Therapy for Periodontal Disease 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Therapeutic Solutions International Inc, Medical Equipment, Key Facts, 2016 2
Therapeutic Solutions International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Therapeutic Solutions International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Therapeutic Solutions International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Therapeutic Solutions International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Therapeutic Solutions International Inc, Deals By Market, 2011 to YTD 2017 8
Therapeutic Solutions International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Therapeutic Solutions Acquires Preterm Labor and Miscarriage Intellectual Property from OmniBiome Therapeutics 10
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International for the Assessment of Pregnancy Complications 11
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International 12
Therapeutic Solutions International Enters into Licensing Agreement with Boyd Research and TMD Courses 13
Therapeutic Solutions Enters Into Distribution Agreement With S4S 14
Therapeutic Solutions Enters into Licensing Agreement with Boyd Research 15
Therapeutic Solutions International Inc, Key Competitors 16
Therapeutic Solutions International Inc, Key Employees 17
Therapeutic Solutions International Inc, Subsidiaries 18

★海外企業調査レポート[Therapeutic Solutions International Inc (TSOI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sedia Biosciences Corp:製品パイプライン分析
    Summary Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It also offers diagnostic products, epidemiological products …
  • Chicago Bridge & Iron Company NV (CBI):電力:M&Aディール及び事業提携情報
    Summary Chicago Bridge & Iron Company NV (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental services …
  • Link Health Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Link Health Group (Link Health) is a pharmaceutical company focused on the discovery and development of novel drug candidates for the treatment of cancer and other diseases. Its pipeline product portfolio includes LH011, an oral small molecule serine protease inhibitor for treating pancreati …
  • Helomics Corp-医療機器分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • United Surgical Partners International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary United Surgical Partners International Inc (United Surgical Partners) is a healthcare service provider that offers ambulatory surgical services. The center provides services in the therapeutical areas of orthopedic, pain management, gynaecology, general surgery, ear, nose, and throat, endosc …
  • Melia Hotels International SA:企業の戦略・SWOT・財務情報
    Melia Hotels International SA - Strategy, SWOT and Corporate Finance Report Summary Melia Hotels International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務分析
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Gavis Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Gavis Pharmaceuticals LLC (GAVIS), a subsidiary of Lupin Ltd is a healthcare products provider that develops, markets and distributes tablets and oral solutions. The company offers products such as cetrizine hydrochloride, clobetasol propionate, dexmethylphenidate hydrochloride, dextroamphet …
  • Croatia Airlines dd:戦略・SWOT・企業財務分析
    Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Valero Energy Corporation:企業の戦略・SWOT・財務情報
    Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Asarina Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycl …
  • Winpak Ltd.:企業の戦略・SWOT・財務情報
    Winpak Ltd. - Strategy, SWOT and Corporate Finance Report Summary Winpak Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ThyssenKrupp AG:企業の戦略・SWOT・財務分析
    ThyssenKrupp AG - Strategy, SWOT and Corporate Finance Report Summary ThyssenKrupp AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Dentsu, Inc.:企業の戦略・SWOT・財務情報
    Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hydrodec Group plc (HYR):企業の財務・戦略的SWOT分析
    Summary Hydrodec Group Plc (Hydrodec) is an oil and gas company that offers oil refining services. The company produces, markets and distributes transformer oil and naphthenic base oil. It undertakes collection, transportation and processing of used non-PCB and PCB-contaminated naphthenic-based tran …
  • NuGEN Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA …
  • Paladin Energy Ltd.:企業の戦略的SWOT分析
    Paladin Energy Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Amtek Auto Limited:企業のM&A・事業提携・投資動向
    Amtek Auto Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amtek Auto Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • American Tower Corp (AMT):企業の財務・戦略的SWOT分析
    American Tower Corp (AMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Broadwind Energy, Inc. (BWEN)-エネルギー分野:企業M&A・提携分析
    Summary Broadwind Energy, Inc. (Broadwind) is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. It offers a wide range of products from gears and gearing systems, to wind turbine towers, fabrications and industrial weldments. B …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆